TY - JOUR
T1 - Germ Cell Testicular Tumors—Contemporary Diagnosis, Staging and Management of Localized and Advanced disease
AU - Goldberg, Hanan
AU - Klaassen, Zachary
AU - Chandrasekar, Thenappan
AU - Fleshner, Neil
AU - Hamilton, Robert J.
AU - Jewett, Michael A.S.
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2019/3
Y1 - 2019/3
N2 - Germ cell testicular tumors are the most commonly diagnosed cancer in young men, with cure rates exceeding 95%. Clinical stage 1 disease is the most common manifestation, with radical orchiectomy curing the majority of Clinical stage 1 patients, making active surveillance the treatment of choice, with a cancer specific survival nearing 100% and low relapse rates. However, in metastatic disease, chemotherapy, radiotherapy, and surgery are curative options. Chemotherapy remains the mainstay of therapy for advanced disease with surgical management of residual disease. Patients with advanced disease should be treated in high volume experienced academic centers with multidisciplinary teams. Research exploring refinement of diagnosis and treatment, and lowering treatment burden is underway.
AB - Germ cell testicular tumors are the most commonly diagnosed cancer in young men, with cure rates exceeding 95%. Clinical stage 1 disease is the most common manifestation, with radical orchiectomy curing the majority of Clinical stage 1 patients, making active surveillance the treatment of choice, with a cancer specific survival nearing 100% and low relapse rates. However, in metastatic disease, chemotherapy, radiotherapy, and surgery are curative options. Chemotherapy remains the mainstay of therapy for advanced disease with surgical management of residual disease. Patients with advanced disease should be treated in high volume experienced academic centers with multidisciplinary teams. Research exploring refinement of diagnosis and treatment, and lowering treatment burden is underway.
UR - http://www.scopus.com/inward/record.url?scp=85059786018&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059786018&partnerID=8YFLogxK
U2 - 10.1016/j.urology.2018.12.025
DO - 10.1016/j.urology.2018.12.025
M3 - Review article
C2 - 30597167
AN - SCOPUS:85059786018
SN - 0090-4295
VL - 125
SP - 8
EP - 19
JO - Urology
JF - Urology
ER -